OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update
Aarti Bhatia, Barbara Burtness
Drugs (2023) Vol. 83, Iss. 3, pp. 217-248
Closed Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Enhancing head and neck tumor management with artificial intelligence: Integration and perspectives
Nian‐Nian Zhong, Hanqi Wang, Xinyue Huang, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 52-74
Closed Access | Times Cited: 43

Global burden of head and neck cancers from 1990 to 2019
Tianjiao Zhou, Weijun Huang, Xiaoting Wang, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109282-109282
Open Access | Times Cited: 14

Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning
Yandan Wang, Chaoqun Zhou, Tian Li, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 9
Open Access | Times Cited: 9

The characterization of tumor immune microenvironment after neoadjuvant immunotherapy in head and neck squamous cell cancer using multiplex immunohistochemistry
Zhaohong An, Xiwei Zhang, Zhaoyang Wang, et al.
Oral Oncology (2025) Vol. 161, pp. 107151-107151
Closed Access | Times Cited: 1

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
Xun Zhu, Jie Qiu, Zhang Ya, et al.
Pharmacological Research (2025) Vol. 212, pp. 107598-107598
Open Access | Times Cited: 1

Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
Shinsuke Suzuki, Yukie Taguchi, Takuro Kitabayashi, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 9, pp. 2456-2456
Open Access | Times Cited: 7

Macrophage Migration Inhibitory Factor (MIF) and D-Dopachrome Tautomerase (DDT): Pathways to Tumorigenesis and Therapeutic Opportunities
Caroline Naomi Valdez, Gabriela Athziri Sánchez‐Zuno, Richard Bucala, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4849-4849
Open Access | Times Cited: 6

Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma
Lin Chen, Yidian Chu, Zheng Ye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Insights into metastatic roadmap of head and neck cancer squamous cell carcinoma based on clinical, histopathological and molecular profiles
Nicholas Mastronikolis, Alexander Delides, Efthymios Kyrodimos, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 5

Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5

Mechanisms of Resistance and Therapeutic Perspectives in Immunotherapy for Advanced Head and Neck Cancers
Andrew Meci, Neerav Goyal, Guy Slonimsky
Cancers (2024) Vol. 16, Iss. 4, pp. 703-703
Open Access | Times Cited: 4

Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma
Lin Dong, Chao Liu, Haoyang Sun, et al.
Cancer Letters (2024) Vol. 593, pp. 216956-216956
Closed Access | Times Cited: 4

GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells
Zoey A. Miller, Sahil Muthuswami, Arielle Mueller, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4

ERBB2 as a Multifaceted Biomarker in Head and Neck Squamous Cell Carcinoma: In Silico and In Vitro Evidence
Syed Hussain Raza, Yasir Hameed
(2025) Vol. 2, Iss. 1, pp. 1-14
Closed Access

Advances in immunotherapy for HNSCC
Dong Lin, Haixia Xu, Xionghao Pang, et al.
(2025) Vol. 2, Iss. 1
Closed Access

Stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: long-term clinical outcome and favorable predictive factors
Viola Salvestrini, Ilaria Bonaparte, Carlotta Becherini, et al.
European Journal of Cancer (2025), pp. 115260-115260
Closed Access

Non-targeted effects of stereotactic radiotherapy: a review of the evidence coming from the clinical field
Angela Barillaro, Mara Caroprese, Chiara Feoli, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access

Real‐World Study of Later‐Line Anlotinib in R/M Head and Neck Squamous Cell Carcinoma
Houyu Ju, Yuanyuan Zhao, Minqi Zhao, et al.
Oral Diseases (2025)
Closed Access

Page 1 - Next Page

Scroll to top